Medfinder
Back to blog

Updated: February 17, 2026

Alternatives to Paxlovid 150 Mg /100 Mg Dose Pack If You Can't Fill Your Prescription

Author

Peter Daggett

Peter Daggett

Alternatives to Paxlovid 150 Mg /100 Mg Dose Pack If You Can't Fill Your Prescription

Can't fill your Paxlovid 150 Mg /100 Mg Dose Pack prescription? Here are real alternative COVID-19 treatments your doctor may recommend in 2026.

When Paxlovid Isn't Available, You Still Have Options

Your doctor prescribed Paxlovid 150 Mg /100 Mg Dose Pack to treat your COVID-19 infection, but your pharmacy doesn't have it in stock. Or maybe a drug interaction makes Paxlovid unsafe for you. Either way, you're wondering: what are the alternatives?

The good news is that there are other FDA-approved and authorized treatments for COVID-19 in high-risk patients. In this article, we'll explain how Paxlovid works, why you might need an alternative, and what your doctor may recommend instead.

What Is Paxlovid 150 Mg /100 Mg Dose Pack?

Paxlovid is an oral antiviral medication made by Pfizer. It combines two drugs:

  • Nirmatrelvir (150 mg): A protease inhibitor that blocks the SARS-CoV-2 virus from replicating
  • Ritonavir (100 mg): A pharmacokinetic booster that slows the breakdown of Nirmatrelvir so it remains effective in your body

The 150 Mg /100 Mg Dose Pack is the renal-adjusted dose, prescribed for patients with moderate kidney impairment (eGFR between 30 and 60 mL/min). The standard dose pack contains a higher amount of Nirmatrelvir (300 mg per dose).

Paxlovid is taken twice daily for 5 days and must be started within 5 days of COVID-19 symptom onset. It is approved for adults at high risk of progressing to severe disease.

How Does Paxlovid Work?

When the SARS-CoV-2 virus infects your cells, it uses an enzyme called the main protease (Mpro) to process the proteins it needs to make copies of itself. Nirmatrelvir blocks this enzyme, effectively stopping the virus from multiplying.

Ritonavir doesn't fight the virus directly. Instead, it inhibits a liver enzyme called CYP3A4 that would normally break down Nirmatrelvir too quickly. By slowing this breakdown, Ritonavir keeps Nirmatrelvir levels high enough to be effective. This is the same reason Ritonavir is used as a booster in many HIV treatments.

However, this CYP3A4 inhibition is also why Paxlovid has so many drug interactions — it affects the metabolism of many other medications.

Why Might You Need an Alternative?

There are several reasons you might not be able to take Paxlovid:

  • Pharmacy doesn't have it in stock: The renal dose pack is stocked in limited quantities
  • Drug interactions: Paxlovid interacts with many common medications, including certain statins (Lovastatin, Simvastatin), blood thinners, immunosuppressants, and heart rhythm medications
  • Severe kidney impairment: Paxlovid is not recommended for patients with eGFR below 30 mL/min
  • Severe liver disease: Paxlovid is contraindicated in patients with severe hepatic impairment
  • Allergic reaction: Prior hypersensitivity to Nirmatrelvir or Ritonavir

Alternative 1: Remdesivir (Veklury)

Remdesivir, sold under the brand name Veklury, is an antiviral made by Gilead Sciences. It was the first FDA-approved treatment for COVID-19 and remains a first-line alternative to Paxlovid.

How it works: Remdesivir is a nucleotide analog that gets incorporated into the virus's RNA chain, causing premature termination of viral replication.

How it's given: For non-hospitalized patients, Remdesivir is administered as an IV infusion over 3 consecutive days at an outpatient infusion center. This is less convenient than taking pills at home, but it's effective and avoids the drug interaction concerns that come with Paxlovid.

Who it's for: Adults and pediatric patients (weighing at least 3.5 kg) with mild-to-moderate COVID-19 who are at high risk of severe disease. It can also be used in hospitalized patients.

Key advantage: Fewer drug interactions than Paxlovid, making it a good option for patients on complex medication regimens.

Alternative 2: Molnupiravir (Lagevrio)

Molnupiravir, sold as Lagevrio, is an oral antiviral made by Merck. It is considered a second-line option — meaning doctors generally try Paxlovid or Remdesivir first.

How it works: Molnupiravir introduces errors into the virus's genetic code during replication, eventually making the virus unable to function. This mechanism is called "lethal mutagenesis."

How it's taken: Four 200 mg capsules taken by mouth twice daily for 5 days (800 mg twice daily).

Who it's for: Adults with mild-to-moderate COVID-19 who are at high risk of progressing to severe disease and for whom other authorized treatments are not accessible or appropriate.

Key considerations: Clinical trials showed Molnupiravir was less effective than Paxlovid at reducing hospitalization and death. It is not recommended for use during pregnancy due to potential risks to the fetus.

Alternative 3: Hospitalization and Supportive Care

If your COVID-19 symptoms progress to severe illness and you haven't been able to access antiviral treatment, you may need hospital-based care. In the hospital setting, treatments may include:

  • IV Remdesivir (longer courses for hospitalized patients)
  • Corticosteroids such as Dexamethasone for patients requiring supplemental oxygen
  • Supportive care including oxygen therapy, fluids, and monitoring

How to Decide Which Alternative Is Right for You

This is a decision to make with your doctor. Factors that influence the choice include:

  • Your current medication list and potential drug interactions
  • Your kidney and liver function
  • Whether you can access an infusion center for Remdesivir
  • How many days since your symptoms started
  • Your personal risk factors for severe COVID-19

Don't try to self-prescribe or choose an alternative on your own. Talk to your healthcare provider about what's safest and most effective for your situation.

Final Thoughts

Paxlovid 150 Mg /100 Mg Dose Pack is the preferred first-line oral treatment for COVID-19 in high-risk patients, but it's not your only option. Remdesivir (Veklury) is an effective IV alternative with fewer drug interactions, and Molnupiravir (Lagevrio) is an oral backup when other treatments aren't available.

If you're having trouble finding Paxlovid, try Medfinder to check pharmacy availability before switching to an alternative. And if you do need a different treatment, your doctor can help you choose the safest option. For more information, read our guides on what Paxlovid is and how it works and how to find Paxlovid in stock near you.

Frequently Asked Questions

No. Clinical trials showed that Molnupiravir was less effective than Paxlovid at reducing hospitalization and death from COVID-19. It is considered a second-line option, used when Paxlovid and Remdesivir are not available or appropriate.

Remdesivir (Veklury) is given as an IV infusion and typically requires a visit to an outpatient infusion center or healthcare facility for 3 consecutive days. Home infusion may be available in some areas through home health services, but this is not standard.

An allergy to Paxlovid (Nirmatrelvir/Ritonavir) does not mean you'll be allergic to Remdesivir or Molnupiravir, as they are completely different drugs. However, always tell your doctor about any drug allergies before starting a new medication.

No. There are no over-the-counter antiviral treatments for COVID-19. All approved COVID-19 antivirals — Paxlovid, Remdesivir, and Molnupiravir — require a prescription. Over-the-counter medications like acetaminophen or ibuprofen can help manage symptoms but do not treat the virus itself.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Paxlovid also looked for:

Lagevrio (molnupiravir)deauthorizedIV antiviralFor patients who cannot take Paxlovid due to drug interactions or contraindications, symptom management with rest, hydration, acetaminophen, and monitoring remains the standard approach.

29,423 have already found their meds with Medfinder.

Start your search today.

29K+
5-star ratingTrusted by 29,423 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?